Edoxaban versus Warfarin in Patients with Atrial FibrillationRobert P. Giugliano, Elliott M. Antman, Stephen D. Wiviott et al.|New England Journal of Medicine|2013Cited by 5.2k
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)Christian T. Ruff, Eugene Braunwald, Robert P. Giugliano et al.|American Heart Journal|2010Cited by 482